A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

NCT07024173 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: HRS-8080 Tablet
DRUG: Fulvestrant injection
DRUG: Exemestane tablets
DRUG: Everolimus Tablets
DRUG: Anastrozole Tablets
DRUG: Letrozole Tablets

Sponsor

Shandong Suncadia Medicine Co., Ltd.